Red-meat sugar Neu5Gc associated with increased type 2 diabetes risk
An observational study presented at EASD found that high intake of dietary Neu5Gc, a sugar common in red meat, was linked to a 63% higher risk of type 2 diabetes. The association remained after adjusting for physical activity, diet, smoking, health conditions, and was weaker but still significant after accounting for BMI. Researchers propose chronic inflammation as a mechanism, noting humans cannot produce Neu5Gc due to an ancient CMAH gene mutation.
The study was observational and preliminary, presented at EASD's Milan meeting. It followed 89,953 French adults from NutriNet-Santé, average age 42 and 79% female, without diabetes or cancer initially. Dietary records estimated Neu5Gc intake; over median 7.2 years, 966 type 2 diabetes cases occurred.
Neu5Gc occurs mainly in beef and lamb, less in dairy. People absorb it into tissues because an ancient CMAH mutation removed human production. It can act as a foreign antigen, prompting antibodies and long-lasting immune stimulation called xenosialitis, previously tied to cardiovascular disease and cancer. Higher meat-derived intake tracked with progressively greater diabetes risk.
If confirmed, this research could affect dietary advice for people at risk of type 2 diabetes, particularly those who often eat beef or lamb. It may give clinicians another way to discuss red-meat patterns beyond weight alone. Consumers and food producers might gradually adjust choices or products, though observational findings cannot establish cause. The impact would likely depend on replication and whether Neu5Gc intake proves modifiable in practice.